Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL1500023	阿柏西普眼内注射溶液	aflibercept	Injection	Biological Products	Import Drug Application	2015-06-15	Bayer Australia Ltd	Bayer Australia Ltd	Certificate Issued	2016-10-13	view
JYHB1502536	屈螺酮炔雌醇片(II)	drospirenone;ethinylestradiol	Tablet	Chemical Drugs	Supplementary Application	2015-12-31	Bayer Australia Ltd	Bayer Australia Ltd;Bayer Weimar Gmbh & Co KG	Certificate Issued	2016-11-17	view
JYHB1800251	屈螺酮炔雌醇片（II）	drospirenone;ethinylestradiol	Tablet	Chemical Drugs	Supplementary Application	2018-03-21	Bayer Australia Ltd	Bayer Australia Ltd;Bayer Weimar Gmbh & Co KG	Certificate Issued	2018-06-27	view
JYHB1800403	屈螺酮炔雌醇片（II）	drospirenone;ethinylestradiol	Tablet	Chemical Drugs	Supplementary Application	2018-04-13	Bayer Australia Ltd	Bayer Australia Ltd;Bayer Weimar Gmbh & Co KG	Certificate Issued	2018-06-12	view
JYHB1801502	屈螺酮炔雌醇片（II）	drospirenone;ethinylestradiol	Tablet	Chemical Drugs	Supplementary Application	2019-01-02	Bayer Australia Ltd	Bayer Australia Ltd;Bayer Weimar Gmbh & Co KG	Certificate Issued	2019-03-13	view
JYHZ1800452	屈螺酮炔雌醇片（II）	drospirenone;ethinylestradiol	Tablet	Chemical Drugs	License Renew	2019-01-07	Bayer Australia Ltd	Bayer Australia Ltd;Bayer Weimar Gmbh & Co KG	Certificate Issued	2019-07-01	view